VERICEL
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Apr 2021)
What this means for you
Registered since 22 Dec 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal was filed 22 Jun 2026 and is awaiting the USPTO's acceptance).
Record
- Serial number
- 86397106
- Registration number
- 4875432
- Mark type
- Word mark
- Filed
- 17 Sept 2014
- Published for opposition
- 10 Feb 2015
- Registered
- 22 Dec 2015
- Next maintenance filing
- §8 & §9 renewal, filed 22 Jun 2026 — awaiting the USPTO's acceptance
- Attorney of record
- JEFFREY H. KAUFMAN
Goods and services
- Class 005 — Pharmaceuticals: Human cells for medical purposes
Owner
- VERICEL CORPORATION, CAMBRIDGE, MA, US
- VERICEL CORPORATION, CAMBRIDGE, MA, US
- VERICEL CORPORATION, CAMBRIDGE, MA, US
- Aastrom Biosciences, Inc., Ann Arbor, MI, US
Board proceedings on this mark
The owner also pleads this mark in 5 other Board proceedings.
Prosecution history
- 25 Aug 2026 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 18 Aug 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Jun 2026 — TEAS SECTION 8 & 9 RECEIVED
- 22 Dec 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 22 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Apr 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Apr 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Apr 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Dec 2020 — TEAS SECTION 8 & 15 RECEIVED
- 22 Dec 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Apr 2016 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Dec 2015 — REGISTERED-PRINCIPAL REGISTER
- 19 Nov 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED